Literature DB >> 12135263

Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China.

Gitte Bartholomot1, Dominique A Vuitton, Said Harraga, Da Zhong Shi, Patrick Giraudoux, Guy Barnish, Yun Hai Wang, Calum N L MacPherson, Philip S Craig.   

Abstract

Alveolar echinococcosis (AE), caused by Echinococcus multilocularis, is a zoonotic helminthic disease that can mimic malignancy. In the 1970s, foci of the disease were found in central China. The aim of the present study was to estimate the prevalence of AE in humans in 2 districts of south Gansu Province, China, by use of ultrasound and Echinococcus serology. After answering an epidemiological questionnaire, 2,482 volunteers from 28 villages underwent ultrasound. Serology via enzyme-linked immunosorbent assay for antibody activity was performed on whole blood collected on filter paper in all subjects; on serum from subjects with an abnormal ultrasound image; and on randomly chosen subjects that either had no lesions or had atypical lesions. At least one (25.3%) abnormal ultrasound image was observed in 630 of the subjects screened. A typical lesion of progressive AE was found in 84 subjects (3.4%). Serologies were positive in 77 (96%) of 80 of patients who had lesions typical of progressive AE. Ultrasound is useful for screening for AE in endemic regions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135263     DOI: 10.4269/ajtmh.2002.66.23

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Use of two sensitive and specific immunoblot markers, em70 and em90, for diagnosis of alveolar echinococcosis.

Authors:  Metin Korkmaz; Tonay Inceboz; Fehmi Celebi; Aylin Babaoglu; Ahmet Uner
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Alveolar echinococcosis in a patient without hepatic disturbance and with unusual humoral immune response.

Authors:  F Persat; C Pariset; B Gottstein; J Ninet; S Picot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-09       Impact factor: 3.267

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 4.  Multimodality imaging in diagnosis and management of alveolar echinococcosis: an update.

Authors:  Mesut Bulakçı; Merve Gülbiz Kartal; Sabri Yılmaz; Erdem Yılmaz; Ravza Yılmaz; Dilek Şahin; Murat Aşık; Oğuz Bülent Erol
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

Review 5.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 6.  The global burden of alveolar echinococcosis.

Authors:  Paul R Torgerson; Krista Keller; Mellissa Magnotta; Natalie Ragland
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

Review 7.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

8.  Widespread co-endemicity of human cystic and alveolar echinococcosis on the eastern Tibetan Plateau, northwest Sichuan/southeast Qinghai, China.

Authors:  Tiaoying Li; Xingwang Chen; Ren Zhen; Jiamin Qiu; Dongchuan Qiu; Ning Xiao; Akira Ito; Hu Wang; Patrick Giraudoux; Yasuhito Sako; Minoru Nakao; Philip S Craig
Journal:  Acta Trop       Date:  2009-11-24       Impact factor: 3.112

Review 9.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

Review 10.  Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern.

Authors:  Johannes Eckert; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.